The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Turning the RING Domain Protein MdmX into an Active Ubiquitin-Protein Ligase*
Abstract
The related RING domain proteins MdmX and Mdm2 are best known for their role as negative regulators of the tumor suppressor p53. However, although Mdm2 functions as a ubiquitin ligase for p53, MdmX does not have appreciable ubiquitin ligase activity. In this study, we performed a mutational analysis of the RING domain of MdmX, and we identified two distinct regions that, when replaced by the respective regions of Mdm2, turn MdmX into an active ubiquitin ligase for p53. Mdm2 and MdmX form homodimers as well as heterodimers with each other. One of the regions identified localizes to the dimer interface indicating that subtle conformational changes in this region either affect dimer stability and/or the interaction with the ubiquitin-conjugating enzyme UbcH5b. The second region contains the cryptic nucleolar localization signal of Mdm2 but is also assumed to be involved in the interaction with UbcH5b. Here, we show that this region has a significant impact on the ability of respective MdmX mutants to functionally interact with UbcH5b in vitro supporting the notion that this region serves two distinct functional purposes, nucleolar localization and ubiquitin ligase activity. Finally, evidence is provided to suggest that the RING domain of Mdm2 not only binds to UbcH5b but also acts as an allosteric activator of UbcH5b.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MDMX (or MDM4), a homolog of MDM2, is structurally similar to MDM2, but it lacks ubiquitin ligase activity and can enhance the ubiquitination activity of MDM2 by forming a dimer with MDM2.337,338”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [338]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280
MDMX: a novel p53‐binding protein with some functional properties of MDM2.
Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648
Parant, J., Chavez-Reyes, A., Little, N. A., Yan, W., Reinke, V., Jochemsen, A. G., & Lozano, G. (2001) · Nature Genetics · doi:10.1038/ng714 · Cited by 517
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
Linares, L. K., Hengstermann, A., Ciechanover, A., Müller, S., & Scheffner, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2030930100 · Cited by 361
Self-citationKeeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4
Marine, J.-C., Francoz, S., Maetens, M., Wahl, G., Toledo, F., & Lozano, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401912 · Cited by 352
MDM2 interacts with MDMX through their RING finger domains
Tanimura, S., Ohtsuka, S., Mitsui, K., Shirouzu, K., Yoshimura, A., & Ohtsubo, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00254-9 · Cited by 324
Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo
Francoz, S., Froment, P., Bogaerts, S., De Clercq, S., Maetens, M., Doumont, G., Bellefroid, E., & Marine, J.-C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508476103 · Cited by 260
MDM2 promotes ubiquitination and degradation of MDMX
Pan, Y., & Chen, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5113-5121.2003 · Cited by 246
Poyurovsky, M. V., Priest, C., Kentsis, A., Borden, K. L., Pan, Z., Pavletich, N., & Prives, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601465 · Cited by 203
Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development
Xiong, S., Van Pelt, C. S., Elizondo-Fraire, A. C., Liu, G., & Lozano, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508500103 · Cited by 155
Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4
Grier, J. D., Xiong, S., Elizondo-Fraire, A. C., Parant, J. M., & Lozano, G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.192-198.2006 · Cited by 149
Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2
de Graaf, P., Little, N. A., Ramos, Y. F. M., Meulmeester, E., Letteboer, S. J. F., & Jochemsen, A. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213034200 · Cited by 143
Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53
Kostic, M., Matt, T., Martinez-Yamout, M. A., Dyson, H. J., & Wright, P. E. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.08.027 · Cited by 128
Research works printed but not linked: 29
- Finch, 2002, Cancer Res., 62, 3221
- Migliorini, 2002, Mol. Cell. Biol., 22, 5527, 10.1128/MCB.22.15.5527-5538.2002 · DOI · Paper page
- Wade, 2009, Mol. Cancer Res., 7, 1, 10.1158/1541-7786.MCR-08-0423 · DOI · Paper page
- Badciong, 2002, J. Biol. Chem., 277, 49668, 10.1074/jbc.M208593200 · DOI
- Singh, 2007, J. Biol. Chem., 282, 10901, 10.1074/jbc.M610879200 · DOI
- Marine, 2004, Cell Cycle, 3, 900, 10.4161/cc.3.7.998 · DOI
- Weissman, 2001, Nat. Rev. Mol. Cell Biol., 2, 169, 10.1038/35056563 · DOI · Paper page
- Kerscher, 2006, Annu. Rev. Cell Dev. Biol., 22, 159, 10.1146/annurev.cellbio.22.010605.093503 · DOI · Paper page
- Deshaies, 2009, Annu. Rev. Biochem., 78, 399, 10.1146/annurev.biochem.78.101807.093809 · DOI · Paper page
- Honda, 1997, FEBS Lett., 420, 25, 10.1016/S0014-5793(97)01480-4 · DOI · Paper page
- Fang, 2000, J. Biol. Chem., 275, 8945, 10.1074/jbc.275.12.8945 · DOI · Paper page
- Honda, 2000, Oncogene., 19, 1473, 10.1038/sj.onc.1203464 · DOI · Paper page
- Saville, 2004, J. Biol. Chem., 279, 42169, 10.1074/jbc.M403362200 · DOI · Paper page
- Uldrijan, 2007, EMBO J., 26, 102, 10.1038/sj.emboj.7601469 · DOI · Paper page
- Linke, 2008, Cell Death Differ., 15, 841, 10.1038/sj.cdd.4402309 · DOI · Paper page
- Migliorini, 2002, J. Biol. Chem., 277, 7318, 10.1074/jbc.M108795200 · DOI
- Li, 2002, Mol. Cell. Biol., 22, 7562, 10.1128/MCB.22.21.7562-7571.2002 · DOI
- Stad, 2001, EMBO Rep., 2, 1029, 10.1093/embo-reports/kve227 · DOI · Paper page
- Lohrum, 2000, Nat. Cell Biol., 2, 179, 10.1038/35004057 · DOI · Paper page
- Weber, 2000, Mol. Cell. Biol., 20, 2517, 10.1128/MCB.20.7.2517-2528.2000 · DOI · Paper page
- Ozkan, 2005, Proc. Natl. Acad. Sci. U.S.A., 102, 18890, 10.1073/pnas.0509418102 · DOI · Paper page
- Meulmeester, 2003, Mol. Cell. Biol., 23, 4929, 10.1128/MCB.23.14.4929-4938.2003 · DOI
- Haupt, 1997, Nature, 387, 296, 10.1038/387296a0 · DOI · Paper page
- Emmott, 2009, EMBO Rep., 10, 231, 10.1038/embor.2009.14 · DOI · Paper page
- Yu, 2006, Proc. Natl. Acad. Sci. U.S.A., 103, 1227, 10.1073/pnas.0510343103 · DOI
- Grossman, 2003, Science, 300, 342, 10.1126/science.1080386 · DOI · Paper page
- Shi, 2009, Proc. Natl. Acad. Sci. U.S.A., 106, 16275, 10.1073/pnas.0904305106 · DOI · Paper page
- Dang, 2002, Cancer Res., 62, 1222
- Das, 2009, Mol. Cell, 34, 674, 10.1016/j.molcel.2009.05.010 · DOI · Paper page
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
RING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination
Metzger, M. B., Pruneda, J. N., Klevit, R. E., & Weissman, A. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.026 · Cited by 611
Metadata
- Authors
- Iyappan, S., Wollscheid, H.-P., Rojas-Fernandez, A., Marquardt, A., Tang, H.-C., Singh, R. K., & Scheffner, M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 285
- Issue
- 43
- Pages
- 33065-33072
- ISSN
- 0021-9258
- Cited by
- 25
- References
- 16
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 3735 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.